title: Effects of 5 alpha-reductase inhibition by finasteride on lipoproteins and body composition in males affected by benign prostatic hyperplasia (BPH).
authors.affiliation: Chair of Geriatrics, University of Parma, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Denti
authors.forename: G
authors.initials: G
authors.lastname: Pasolini
authors.forename: P
authors.initials: P
authors.lastname: Cortellini
authors.forename: L
authors.initials: L
authors.lastname: Sanfelici
authors.forename: R
authors.initials: R
authors.lastname: Benedetti
authors.forename: A
authors.initials: A
authors.lastname: Cecchetti
authors.forename: S
authors.initials: S
authors.lastname: Ferretti
authors.forename: A
authors.initials: A
authors.lastname: Banchini
authors.forename: F
authors.initials: F
authors.lastname: Ablondi
authors.forename: G
authors.initials: G
authors.lastname: Valenti
mesh_terms: D000368:Aged; D001823:Body Composition / Q000187:drug effects*; D042944:Cholestenone 5 alpha-Reductase; D013196:Dihydrotestosterone / Q000097:blood; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D018120:Finasteride / Q000627:therapeutic use*; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011470:Prostatic Hyperplasia / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology* / Q000473:pathology*
chemical_list: D004791:Enzyme Inhibitors; D008074:Lipoproteins; D013196:Dihydrotestosterone; D018120:Finasteride; D010088:Oxidoreductases; D042944:Cholestenone 5 alpha-Reductase